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Regarding “The development of the
postthrombotic syndrome in relationship to
venous reflux and calf muscle pump dysfunction at
2 years after the onset of deep venous thrombosis”
Seshadri Raju, MD, Jackson, Miss
Haenen and colleagues present a prospective study of
the early evolution of postthrombotic syndrome (PTS) in
this issue of the Journal of Vascular Surgery. The authors
found that significant signs of PTS (CEAP classification 3
or higher) were evident in 53% of limbs as early as 2 years
after the onset of acute deep venous thrombosis (DVT);
reflux had developed concurrently (23% to 36% incidence
rate) in a number of superficial and deep venous segments
monitored. PTS severity correlated with superficial but not
deep reflux. Pain, an important component of PTS, was not
considered in the clinical evaluation of PTS. The CEAP
classification does not include the pain component in as-
signing clinical class. Recently developed quality-of-life cri-
teria for use in chronic venous insufficiency do include pain
and may provide a more complete picture of PTS severity.
The pathologic findings detailed in this study provide a
time-specific (2 years) snapshot of a process that evolves
over many more years, often with transient intermediate
findings. Variance in some details from other publications
may be attributable to this and to technologic limitations
(see subsequent).
The current and related recent publications by Haenen
et al and similar studies by other investigators1-4 confirm in
general the original seminal work of Strandness and col-
leagues on PTS evolution. In a remarkable series of papers
(many appearing in this journal), the University of Wash-
ington researchers used serial duplex scan examinations in
patients with DVT to illuminate most of the salient features
currently known regarding the evolution of thrombus and
PTS. It is now known that thrombus evolution is a dynamic
and often unstable process with simultaneous regression
and progression occurring in different venous segments.
Progression was more likely to occur in the proximal ve-
nous segments. Increasing age and slow rate of thrombus
resolution were negative factors in ultimate resolution.
About 15% to 20% of superficial femoral veins remain
occluded2,4 but with excellent collateral development from
the deep femoral vein. The process of PTS evolution was
continuous, spanning years, not months.3 The distribution
and number of occluded and refluxive venous segments at 8
to 12 years1,4 are far different from those encountered in
shorter term linear studies, such as the one presented by
Haenen and colleagues. Partial or total lysis/recanalization
occurs in most venous segments by 6 months.2,3 By 8 to 12
years, more than 75% of previously occluded venous seg-
ments have partially or fully recanalized.3,5 However, com-
plete resolution occurs in only about a third of the limbs,5
with residual segmental lesions persisting in the great ma-
jority. Test results of venous function remain abnormal in
70% to 83% of postthrombotic limbs. Reflux invariably
occurs in venous segments with partial recanalization.4
Reflux was more likely to occur in previously thrombosed
segments, but there is a significant incidence rate of reflux
development in previously nonthrombosed segments6 as
well. The latter category of nonthrombotic reflux mostly
occurs in venous segments distal to the thrombus but
curiously, in about 12% of limbs, develops in proximal
segments. Reflux, especially the nonthrombotic variety, can
be transient, with surprisingly high (40%) incidence rates in
some locations.6 The nonthrombotic reflux was not the
result of segment dilatation,7 and the causative mechanism
remains unknown. With time, both superficial and deep
reflux develop in about two thirds of postthrombotic limbs,
but the rate of development of superficial reflux is similar to
that of the contralateral nonthrombotic extremity.8 Unlike
Haenen and colleagues, the University of Washington
group found no correlation between PTS and the develop-
ment of superficial reflux. Complete lysis of thrombus,
especially when it occurs rapidly (90 days), restores lumi-
nal size, compliance, and valve integrity to normal values in
the involved venous segment.2,9 However, in some in-
stances, venous segments that took as much as 6 months to
clear the thrombus were competent! Many of the prior
findings were previously unsuspected and have important
therapeutic implications. On the basis of prior histologic
studies of thrombosed venous segments, it had been as-
sumed that fibrous organization of the thrombus was the
inevitable outcome and the delicate valve structures were
destroyed in the process. The University of Washington
group also established that combined obstruction/reflux
was the dominant lesion encountered in the postthrom-
botic extremity.5 However, hemodynamic confirmation of
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the obstructive component with functional tests remains
difficult.1 This may be related to the rapid development of
collaterals but is more likely a reflection of the relative
insensitivity of currently available techniques for assessment
of obstruction. Indirect evidence that residual iliac venous
obstruction plays a major role in PTS comes from recent
favorable clinical experience with iliac venous stent place-
ment.10 Interestingly, stasis ulcers—generally attributed to
reflux, not obstruction—healed in 62% of limbs after stent
placement, although the refluxive component remained
uncorrected. It is clear that the complex interplay between
reflux and obstruction in the PTS limb is poorly under-
stood. The iliac venous segment has been generally ignored
in most serial studies dealing with PTS because the duplex
scan technology is not well suited for this purpose.
There is wide disagreement regarding the relative im-
portance of superficial versus deep reflux and proximal
versus distal reflux in the genesis of PTS.2,3,8,11 Most
groups, including Haenen and colleagues, use valve closure
time (VCT) of more than 1 second (0.5 second in some
instances) as a definition of reflux. This is at best a qualita-
tive measure. Several previous attempts to use VCT and
related indices in this manner to correlate with symptoms of
chronic venous insufficiency have failed. In our own labo-
ratory, we have observed that the rate of volumetric reflux
(calculated from absolute VCT duration, time averaged
reflux velocity, and valve station area) can vary widely
among refluxive (VCT  1 second) valve stations from as
little as a few mL/min to one or more magnitudes higher
(10 mL to1000 mL)! All “reflux” is not the same. The
controversies regarding the relative importance of various
regional reflux patterns and PTS are unlikely to be resolved
until a more precise measure of reflux is developed and
applied.
Prospective studies have now clearly established the
very high incidence and morbidity rates of PTS after cur-
rent heparin/warfarin anticoagulation protocols for the
treatment of DVT. Recurrent DVT (about 30% incidence
rate at 10 years) and inadequate strength or duration of
warfarin anticoagulation therapy further increase the inci-
dence rate of PTS.5,12 Use of low–molecular-weight hepa-
rins has not reduced the incidence rate of PTS.12 Stockings
have been shown to be of little use as a preventive mea-
sure.13 Better monitoring and longer term warfarin therapy
may reduce the incidence rate of PTS somewhat, but a
meaningful reduction seems unlikely without a major shift
in therapeutic stratagem. The study by Haenen et al and
other similar studies suggest that a successful new strategy
must focus on the early and complete lysis of the thrombus
load after the onset of DVT.
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Please see the related article by Dr Jose´ H. Haenen et al
on pages 1184-9.
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